c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways

Area of Science:

• * Molecular biology
• * Cell biology
• * Cancer research

Background:

• * c-Myc overexpression drives cell cycle progression and apoptosis, but the role of cell cycle dysregulation in c-Myc-induced apoptosis remains unclear.
• * Ornithine decarboxylase (ODC) is a c-Myc transcriptional target implicated in c-Myc-induced apoptosis.
• * Interleukin-3 (IL-3)-dependent 32D.3 myeloid cells are used as a model system.

Purpose of the Study:

• * To investigate the role of ODC in c-Myc-induced apoptosis and cell cycle regulation.
• * To determine if ODC overexpression alone can induce apoptosis without cell cycle dysregulation.
• * To elucidate the relationship between c-Myc-mediated cell cycle progression and apoptosis pathways.

Main Methods:

• * Overexpression of ODC and c-Myc in 32D.3 myeloid cells.
• * Analysis of cell cycle progression using flow cytometry.
• * Induction of apoptosis assays.
• * Treatment with dibutyryl cyclic AMP (Bt2cAMP) to inhibit cell cycle progression.

Main Results:

• * High ODC overexpression induced apoptosis in 32D.3 cells similarly to c-Myc, but without cell cycle dysregulation.
• * ODC was found to be essential downstream of c-Myc for myeloid cell growth.
• * Bt2cAMP treatment arrested c-Myc-overexpressing cells in G1 phase without inducing apoptosis, but apoptosis could still be induced upon IL-3 withdrawal.
• * These findings suggest separable pathways for c-Myc-induced cell cycle progression and apoptosis.

Conclusions:

• * c-Myc-induced apoptosis and cell cycle progression are separable processes that share common mediators.
• * ODC overexpression can trigger apoptosis independently of cell cycle dysregulation.
• * A "multiple effectors" model is proposed where c-Myc regulates mediators sufficient for apoptosis but required in concert for cell cycle progression.